BR112012014954A2 - método para diagnosticar tumor maligno - Google Patents
método para diagnosticar tumor malignoInfo
- Publication number
- BR112012014954A2 BR112012014954A2 BR112012014954A BR112012014954A BR112012014954A2 BR 112012014954 A2 BR112012014954 A2 BR 112012014954A2 BR 112012014954 A BR112012014954 A BR 112012014954A BR 112012014954 A BR112012014954 A BR 112012014954A BR 112012014954 A2 BR112012014954 A2 BR 112012014954A2
- Authority
- BR
- Brazil
- Prior art keywords
- malignant tumor
- therapeutic
- therapeutic method
- severity
- soluble
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
método para diagnosticar tumor maligno. fornecer um método e um kit diagnóstico para determinar a presença de um tumor maligno ou a severidade do mesmo, um método para selecionar um método terapêutico para este ou avaliar o efeito do método terapêutico, ou método para calcular o risco de retorno do tumor maligno ou determinar a presença ou ausência do retorno. o método para determinar a presença de um tumor maligno ou a severidade do mesmo, método para selecionar um método terapêutico para este ou avaliar o efeito do método terapêutico, ou método para calcular o risco de retorno do tumor maligno ou a presença ou ausência do retorno é caracterizado incluindo 1) uma etapa de medir a concentração e/ou quantidade de lr11 solúvel em uma amostra originando-se de um indivíduo e 2) uma etapa de comprar o valor medido acima com um valor de medida de lr11 solúvel obtido de um grupo de indivíduo saudável.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009285492 | 2009-12-16 | ||
| JP2009-285492 | 2009-12-16 | ||
| JP2010-120390 | 2010-05-26 | ||
| JP2010120390 | 2010-05-26 | ||
| PCT/JP2010/072521 WO2011074594A1 (ja) | 2009-12-16 | 2010-12-15 | 悪性腫瘍の診断方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012014954A2 true BR112012014954A2 (pt) | 2016-12-13 |
| BR112012014954B1 BR112012014954B1 (pt) | 2020-11-24 |
Family
ID=44167345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012014954-7A BR112012014954B1 (pt) | 2009-12-16 | 2010-12-15 | Metodo para diagnosticar tumor maligno |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9097714B2 (pt) |
| EP (1) | EP2515114B1 (pt) |
| JP (1) | JP5783909B2 (pt) |
| KR (1) | KR101832199B1 (pt) |
| CN (1) | CN102656456B (pt) |
| AU (1) | AU2010331291B2 (pt) |
| BR (1) | BR112012014954B1 (pt) |
| CA (1) | CA2783308C (pt) |
| MX (1) | MX2012007009A (pt) |
| RU (1) | RU2595854C2 (pt) |
| WO (1) | WO2011074594A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2012008595A1 (ja) * | 2010-07-15 | 2013-09-09 | 積水メディカル株式会社 | 抗ｌｒ１１抗体の製造法及び免疫学的測定用標準品 |
| CN103003695B (zh) | 2010-07-15 | 2016-08-17 | 积水医疗株式会社 | 恶性肿瘤细胞的检测方法 |
| EP2708893B1 (en) | 2011-05-09 | 2017-04-19 | Sekisui Medical Co., Ltd. | Method for immunologically measuring soluble LR11 |
| JP6041297B2 (ja) * | 2012-08-24 | 2016-12-07 | 国立大学法人山口大学 | 犬リンパ腫の診断方法及び診断キット |
| JP6116938B2 (ja) * | 2013-02-28 | 2017-04-19 | 学校法人順天堂 | 新規な肺高血圧症のマーカー |
| JP6166062B2 (ja) * | 2013-02-28 | 2017-07-19 | 積水メディカル株式会社 | 肝臓疾患の評価方法及び診断キット |
| RU2662709C1 (ru) * | 2016-06-27 | 2018-07-26 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ диагностики дисплазии и рака шейки матки у женщин репродуктивного возраста |
| RU2663309C1 (ru) * | 2016-06-27 | 2018-08-03 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Способ диагностики крауроза вульвы у женщин в менопаузе |
| EP3879270A4 (en) * | 2018-11-09 | 2022-08-10 | Sekisui Medical Co., Ltd. | METHOD FOR DETECTION OF LIVER CANCER OF VIRAL ORIGIN |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09163988A (ja) | 1995-10-09 | 1997-06-24 | Kowa Co | 新規なｌｄｌ受容体類似蛋白質及び遺伝子 |
| DE10136273A1 (de) * | 2001-07-25 | 2003-02-13 | Sabine Debuschewitz | Molekulare Marker beim hepatozellulären Karzinom |
| WO2003036264A2 (en) * | 2001-10-26 | 2003-05-01 | Immunex Corporation | Treating diseases mediated by metalloprotease-shed proteins |
| WO2004040014A2 (en) * | 2002-11-01 | 2004-05-13 | Aros Applied Biotechnology Aps | Gene expression in biological conditions |
| WO2005015236A2 (en) * | 2003-07-18 | 2005-02-17 | Roche Diagnostics Gmbh | A method for predicting the progression of adenocarcinoma |
| US20110177610A1 (en) | 2007-06-18 | 2011-07-21 | Sekisui Medical Co., Ltd. | Novel marker for arteriosclerotic disease |
| WO2009116268A1 (ja) | 2008-03-21 | 2009-09-24 | 積水メディカル株式会社 | 可溶性ｌｒ１１の定量方法 |
| WO2011027308A1 (en) * | 2009-09-03 | 2011-03-10 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
-
2010
- 2010-12-15 AU AU2010331291A patent/AU2010331291B2/en active Active
- 2010-12-15 CN CN201080056852.2A patent/CN102656456B/zh active Active
- 2010-12-15 KR KR1020127010487A patent/KR101832199B1/ko active IP Right Grant
- 2010-12-15 EP EP10837620.3A patent/EP2515114B1/en active Active
- 2010-12-15 RU RU2012129913/15A patent/RU2595854C2/ru active
- 2010-12-15 JP JP2011546140A patent/JP5783909B2/ja active Active
- 2010-12-15 CA CA2783308A patent/CA2783308C/en active Active
- 2010-12-15 WO PCT/JP2010/072521 patent/WO2011074594A1/ja active Application Filing
- 2010-12-15 MX MX2012007009A patent/MX2012007009A/es active IP Right Grant
- 2010-12-15 US US13/512,903 patent/US9097714B2/en active Active
- 2010-12-15 BR BR112012014954-7A patent/BR112012014954B1/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| RU2595854C2 (ru) | 2016-08-27 |
| JPWO2011074594A1 (ja) | 2013-04-25 |
| BR112012014954B1 (pt) | 2020-11-24 |
| US9097714B2 (en) | 2015-08-04 |
| WO2011074594A1 (ja) | 2011-06-23 |
| JP5783909B2 (ja) | 2015-09-24 |
| RU2012129913A (ru) | 2014-01-27 |
| CA2783308A1 (en) | 2011-06-23 |
| CN102656456B (zh) | 2015-04-08 |
| EP2515114A1 (en) | 2012-10-24 |
| KR101832199B1 (ko) | 2018-04-13 |
| AU2010331291B2 (en) | 2016-04-14 |
| CN102656456A (zh) | 2012-09-05 |
| KR20120123248A (ko) | 2012-11-08 |
| AU2010331291A1 (en) | 2012-06-21 |
| EP2515114B1 (en) | 2017-11-15 |
| EP2515114A4 (en) | 2012-12-05 |
| CA2783308C (en) | 2018-10-16 |
| MX2012007009A (es) | 2012-07-03 |
| US20130029363A1 (en) | 2013-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012014954A2 (pt) | método para diagnosticar tumor maligno | |
| BR112012019542A2 (pt) | "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit" | |
| MX357550B (es) | Microarn plasmaticos para la deteccion de cancer colorrectal temprano. | |
| JP2018509934A5 (pt) | ||
| BRPI1005609A2 (pt) | método e sistema de suficiência para preenchimento | |
| CR20130070A (es) | Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor | |
| EP2759259A3 (en) | Apparatus and method for measuring stress based on a behavior of a user | |
| BR112013000760A2 (pt) | método e aparelho para medir a espessura do tecido adiposo | |
| EA201170361A1 (ru) | Ценный документ и способ определения степени загрязнения или изнашивания такого документа | |
| HRP20130127T1 (hr) | Prediktivni biomarkeri bubrežne sigurnosti i potpisi biomarkera za praä†enje funkcije bubrega | |
| BR112014019564A8 (pt) | Método para determinar a permeabilidade ou uma propriedade indicativa da permeabilidade de um reservatório | |
| WO2013137992A3 (en) | Downhole systems and methods for water source determination | |
| ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| WO2007103116A3 (en) | Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair | |
| HK1115636A1 (en) | Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1 | |
| BR112014007726A2 (pt) | medidor de teste manual com circuito de medição de hematócrito com base em deslocamento de fase | |
| EA201290793A1 (ru) | Зонд для определения границ между веществами | |
| ATE535782T1 (de) | Verfahren und vorrichtung zur salzgehaltunabhängigen messung von nichthomogenen strömungsphasenverhältnissen | |
| WO2010136163A8 (en) | Secernin-1 as a marker for cancer | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| ATE426168T1 (de) | Verwendung von asc als marker fur kolorektalkarzinome | |
| GB201206323D0 (en) | Methods and arrays for use in the same | |
| EP2044212A4 (en) | METHOD FOR IDENTIFYING PATIENTS WITH INCREASED RISK FOR AN UNWANTED HEART CIRCUIT EVENT | |
| EP2554993A4 (en) | MARKER FOR THE DIAGNOSIS OF THE EFFECT OF ANTICREMULATION | |
| MX2011009387A (es) | Elemento de prueba para analizar un fluido corporal y metodo para su medicion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law | ||
| B09A | Decision: intention to grant | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/12/2010, OBSERVADAS AS CONDICOES LEGAIS. |